Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.65 USD | +3.42% | +12.09% | +36.65% |
22/04 | Sector Update: Health Care Stocks Advance Premarket Monday | MT |
22/04 | Kura Oncology Gets Breakthrough Designation For Leukemia Therapy | DJ |
Business Summary
Number of employees: 142
Managers
Managers | Title | Age | Since |
---|---|---|---|
Troy Wilson
CEO | Chief Executive Officer | 55 | 22/14/22 |
Stephen Dale
CTO | Chief Tech/Sci/R&D Officer | 52 | 25/20/25 |
Kathleen Ford
COO | Chief Operating Officer | 77 | 09/19/09 |
Pete de Spain
IRC | Investor Relations Contact | - | 01/17/01 |
Thomas Doyle
AUD | Comptroller/Controller/Auditor | 53 | 01/21/01 |
Brian Powl
PRN | Corporate Officer/Principal | - | 14/23/14 |
Mollie Leoni
PRN | Corporate Officer/Principal | - | 01/20/01 |
Teresa Bair
LAW | General Counsel | 53 | 18/21/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Carol Schafer
BRD | Director/Board Member | 60 | 03/21/03 |
Faheem Hasnain
BRD | Director/Board Member | 65 | 27/15/27 |
Thomas Malley
BRD | Director/Board Member | 55 | 14/15/14 |
Mary Szela
BRD | Director/Board Member | 61 | 06/18/06 |
Troy Wilson
CEO | Chief Executive Officer | 55 | 22/14/22 |
Diane Parks
BRD | Director/Board Member | 72 | 14/19/14 |
Helen Collins
BRD | Director/Board Member | 61 | 29/21/29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,180,620 | 73,510,311 ( 96.49 %) | 0 | 96.49 % |
Company contact information
Kura Oncology, Inc.
12730 High Bluff Drive Suite 400
92130, San Diego
+858 500 8800
http://www.kuraoncology.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.65% | 1.5B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- KURA Stock
- Company Kura Oncology, Inc.